Aldeyra Therapeutics (ALDX) Tops Q2 EPS by 8c

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q2 EPS of ($0.27), $0.08 better than the analyst estimate of ($0.35).

For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.

You May Also Be Interested In

• UBS sees a negative catalyst ahead for Nike: Here’s what to watch
• Trio-Tech wins $4.7M automotive semiconductor burn-in contract
• Analysts eye Intuit investor day for signs estimates have troughed